𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Development of consensus guidelines for venous thromboembolism prophylaxis in patients undergoing microvascular reconstruction of the mandible

✍ Scribed by Frederic W.-B. Deleyiannis; Julio A. Clavijo-Alvarez; Benson Pullikkotil; Rami Zanoun; Tiffany Behringer; Tae W. Chong; J. Peter Rubin; Jonas T. Johnson


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
103 KB
Volume
33
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Background

The purpose of this study was to determine how guidelines for venous thromboembolism prophylaxis can be applied to patients undergoing microsurgical reconstruction of the mandible.

Methods

Retrospective review of our institutional use of thromboprophylaxis and the associated outcomes in 114 patients (58 free fibular flaps and 56 osteocutaneous radial forearm flaps).

Results

Twenty‐two patients (19.3%) received only intermittent pneumatic compression. Overall, 80.7% received postoperative chemoprophylaxis. Sixty‐four percent initiated chemoprophylaxis within 24 hours after surgery. Only 13.2% received the recommended frequency of chemoprophylaxis. One patient had development of a pulmonary embolism. Four patients undergoing chemoprophylaxis had development of neck hematomas; in each case the cause of bleeding could be attributed to a cause distinct from chemoprophylaxis.

Conclusions

No consistent chemoprophylaxis protocol was followed. Chemoprophylaxis was not associated with an increased risk of bleeding. Physician education is the next step in decreasing variations in chemoprophylaxis and adopting guidelines similar to The American College of Chest Physicians. © 2010 Wiley Periodicals, Inc. Head Neck, 2011


📜 SIMILAR VOLUMES


Venous thromboembolism prophylaxis in me
✍ Jason M. Stinnett; Robert Pendleton; LeAnne Skordos; Michelle Wheeler; George M. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 2 views

Venous thromboembolism (VTE) is common but often unrecognized in medically ill patients. Over the past 5 years, three large-scale placebo-controlled trials enrolling a total of 5500 medically ill patients have highlighted the risk of VTE in this group. These trials have helped to define a specific a